A coalition of leading international patient-led organizations today announced the formal establishment of the CURE SYNGAP1 ...
The gene SYNGAP1, the variants of which are top risk factors for Autism Spectrum Disorder (ASD), has previously unappreciated effects on the developing brain, according to a new study published in ...
Mill Valley, CA – April 15, 2026 – CURE SYNGAP1, the premier global patient advocacy group dedicated to transforming the lives of those living with SYNGAP1-Related Disorders (SRD), today announced ...
Researchers at Children's Hospital of Philadelphia (CHOP) have found that in rare instances, variants responsible for SYNGAP1-related disorders—a group of disorders characterized by developmental ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. In early January 2014, my wife and I drove to the hospital in ...
CAMP4 Therapeutics reports promising results for CMP-SYNGAP-01 and CMP-CPS-001 in treating genetic disorders, with favorable safety data. CAMP4 Therapeutics announced promising results from its ...
ATLANTA — June 21 is International SYNGAP1 Awareness Day, bringing awareness to a rare genetic disorder you may have never even heard of, but Atlanta parents, Suzanne and Brent Jones are working to ...
SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment, causing epilepsy, intellectual disability, psychomotor delay and, frequently, autism. It is caused by mutations in ...
The gene SYNGAP1, the variants of which are top risk factors for Autism Spectrum Disorder (ASD), has previously unappreciated effects on the developing brain, according to a new study published in ...
57 hours and 56 minutes. That's how long it took three dads to drive across the country to raise money for their sons' rare genetic disease. Last week, Brett Stelmaszek, Kevin Frye and Peter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results